Charles Kuzma is an Oncology physician affiliated with FirstHealth of the Carolinas. OpenAlex indexes 32 publications with 3,951 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
12 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
55.3%Aromatase Inhibitor17.8%Letrozole66%Anastrozole34%Part D≥35 patientsThalidomide Analog14.9%Revlimid63%Lenalidomide29%Pomalyst9%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
15.5%Serotonin-3 Receptor Antagonist7.3%Ondansetron Hcl72%Ondansetron Odt28%Part D<11 patientsPotassium supplement3.1%Potassium Chloride100%Part D≥11 patients+ 3 more classes in this area
Nervous system
11%Gabapentinoids5.6%Gabapentin100%Part D≥11 patientsPhenothiazine3.9%Prochlorperazine Maleate100%Part D≥29 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”